Induction of vaginal Lactobacillus phages by the cigarette smoke chemical benzo[a]pyrene diol epoxide

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 466, Issue 1, 2000, Pages 57-62

  Pavlova, Sylvia I ^a   Tao, Lin ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Bacterial vaginosis; BPDE; Lactobacilli; Phage; Smoking

Indexed keywords

ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; DISEASE ASSOCIATION; FEMALE; HUMAN; LACTOBACILLUS; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SMOKING; VAGINA FLORA; VAGINITIS;

7,8-DIHYDRO-7,8-DIHYDROXYBENZO(A)PYRENE 9,10-OXIDE; BACTERIOPHAGES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LACTOBACILLUS; LYSOGENY; MUTAGENS; SMOKING; VAGINA; VAGINOSIS, BACTERIAL;

BACTERIA (MICROORGANISMS); LACTOBACILLUS; NICOTIANA TABACUM;

EID: 0034599157     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(00)00003-6     Document Type: Article

References (23)

1. [1] S.L. Hillier, R.P. Nugent, D.A. Eschenbach, M.A. Krohn, R.S. Gibbs, D.H. Martin, M.F. Cotch, R. Edelman, J.G. Pastorek, A.V. Rao, D. McNellis, J.A. Regan, J.C. Carey, M.A. Klebanoff, The vaginal infections and prematurity study group, association between bacterial vaginosis and preterm delivery of a low birth-weight infant, N. Engl. J. Med. 333 (1995) 1737-1742.
2. [2] P.G. Larsson, J.J. Platz-Christensen, E. Sundstrom, Is bacterial vaginosis a sexually transmitted disease?, Int. J. STD AIDS 2 (1991) 362-364.
3. + levels, J. Acquired Immune Defic. Syndr. 7 (1994) 718-726.
4. [4] N. Sewankambo, R.H. Gray, M.J. Wawer, L. Paxton, D. McNaim, F. Wabwire-Mangen, D. Serwadda, C. Li, N. Kiwanuka, S. Hillier, L. Rabe, C.A. Gaydos, T.C. Quinn, J. Konde-Lule, HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis, Lancet 350 (1997) 546-550.
5. 2 negative or without Lactobacillus vaginal colonization, Proceedings of Infectious Disease Society for Obstetrics and Gynecology, Annual Scientific Meeting and Symposium, Toronto, Canada, 1999, p. 13.
6. [6] S.I. Pavlova, A.O. Kilic, S.M. Mou, L. Tao, Phage infection in vaginal lactobacilli: an in vitro study, Infect. Dis. Ob. Gyn. 5 (1997) 36-44.
7. [7] S.I. Pavlova, A.O. Kilic, J. Clarridge, L. Tao, Phage infection and transmission in vaginal lactobacilli: initial evidence, The 99th General Meeting of American Society for Microbiology, 1999, p. 213, Abstract, D/B 20.
8. [8] I.M. Sasson, N.J. Haley, D. Hoffmann, E.L. Wynder, D. Hellberg, S. Nilsson, Cigarette smoking and neoplasia of the uterine cervix: smoke constituents in cervical mucus (Letter), N. Engl. J. Med. 312 (1985) 315-316.
9. [9] E.A. Holly, N.L. Petrakis, N.F. Friend, D.L. Sarles, R.E. Lee, L.B. Flander, Mutagenic mucus in the cervix of smokers, J. Natl. Cancer Inst. 76 (1986) 983-986.
10. [10] E.A. Holly, R.D. Cress, D.K. Ahn, D.A. Aston, J.J. Kristiansen, R. Wu, J.S. Felton, Detection of mutagens in cervical mucus in smokers and nonsmokers, Cancer Epidemiol. Biomarkers Prev. 2 (1993) 223-228.
11. [11] B. Prokopczyk, J.E. Cox, D. Hoffmann, S.E. Waggoner, Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers, J. Natl. Cancer Inst. 89 (1997) 868-873.
12. [12] W.A. Poppe, R. Peeters, P. Daenens, P.S. Ide, F.A. Van Assche, Tobacco smoking and the uterine cervix: cotinine in blood, urine and cervical fluid, Gynecol. Obstet. Invest. 39 (1995) 110-114.
13. [13] R.R. Raya, E.G. Kleeman, J.B. Luchansky, T.R. Klaenhammer, Characterization of the temperate bacteriophage φadh and plasmid transduction in Lactobacillus acidophilus ADH, Appl. Environ. Microbiol. 55 (1989) 2206-2213.
14. [14] A.O. Kilic, S.I. Pavlova, W. Ma, L. Tao, Analysis of Lactobacillus phages and bacteriocins in American dairy products and characterization of a phage isolated from yogurt, Appl. Environ. Microbiol. 62 (1996) 2111-2116.
15. [15] D.E. Bradley, Ultrastructure of bacteriophage and bacteriocin, Bacteriol. Rev. 31 (1967) 230-314.
16. [16] D. Hoffmann, S.S. Hecht, Nicotine-derived N-nitrosamines and tobacco-related cancer: current status and future direction, Cancer Res. 45 (1985) 935-944.
17. [17] M.F. Denissenko, A. Pao, M. Tang, G.P. Pfeifer, Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hot spots in P53, Science 274 (1996) 430-432.
18. [18] K.D. Brunnemann, D. Hoffmann, Analytical studies on tobacco-specific N-nitrosamines in tobacco and tobacco smoke, Crit. Rev. Toxicol. 21 (1991) 235-240.
19. [19] R. Pacifici, I. Altieri, L. Gandini, A. Lenzi, S. Pichini, M. Rosa, P. Zuccaro, F. Dondero, Nicotine, cotinine, and trans-3-hydroxycotinine levels in seminal plasma of smokers: effects on sperm parameters, Ther. Drug Monit. 15 (1993) 358-363.
20. [20] R. Mancini, G. Romano, A. Sgambato, G. Flamini, M.R. Giovagnoli, A. Boninsegna, C. Carraro, A. Vecchione, A. Cittadini, Polycyclic aromatic hydrocarbon - DNA adducts in cervical smears of smokers and nonsmokers, Gynecol. Oncol. 75 (1999) 68-71.
21. [21] M.T. Zenzes, R. Bielecki, T.E. Reed, Detection of benzo(a)pyrene diol epoxide - DNA adducts in sperm of men exposed to cigarette smoke, Fertil. Steril. 72 (1999) 330-335.
22. [22] J.W. Roberts, C.W. Roberts, N.L. Craig, Escherichia coli recA gene product inactivates phage lambda repressor, Proc. Natl. Acad. Sci. U.S.A. 75 (1978) 4714-4718.
23. [23] P. Venier, R. Montini, M. Zordan, E. Clonfero, M. Paleologo, A.G. Levis, Induction of SOS response in Escherichia coli strain PQ37 by 16 chemical compounds and human urine extracts, Mutagenesis 4 (1989) 51-57.